Global Patent Index - EP 4081664 A4

EP 4081664 A4 20240110 - MICROBIOME OPTIMIZATION

Title (en)

MICROBIOME OPTIMIZATION

Title (de)

MIKROBIOMOPTIMIERUNG

Title (fr)

OPTIMISATION DU MICROBIOME

Publication

EP 4081664 A4 20240110 (EN)

Application

EP 20905639 A 20201219

Priority

  • US 201962953068 P 20191223
  • US 202063005243 P 20200404
  • US 202016943895 A 20200730
  • US 202063075132 P 20200905
  • US 2020066269 W 20201219

Abstract (en)

[origin: WO2021133697A1] The present disclosure provides compositions and methods for acidic compositions for use in optimizing the genital microbiome of a user or sexual partners of that user. The compositions may comprise a prebiotic oligosaccharide, a metal co-factor, and an essential oil comprising bomyl acetate. The compositions support the genital microbiota and are useful for, for example, hydrating, lubricating, cleaning, and/or decreasing irritation or inflammation of the urogenital and/or anogenital region of a subject, and/or enhancing the beneficial genital microbiota of a subject. Such compositions are useful before, during, and/or after sexual and/or reproductive activity. Furthermore, the compositions may have minimal or beneficial effect on gametes.

IPC 8 full level

A61K 31/045 (2006.01); A61K 31/7016 (2006.01); A61K 33/32 (2006.01); A61K 47/14 (2017.01); A61P 15/00 (2006.01); C12Q 1/6883 (2018.01); C12Q 1/689 (2018.01); G16H 10/40 (2018.01); G16H 20/10 (2018.01); G16H 20/13 (2018.01); G16H 40/63 (2018.01); G16H 40/67 (2018.01); G16H 50/20 (2018.01); G16H 50/30 (2018.01)

CPC (source: EP)

A61K 31/045 (2013.01); A61K 31/7016 (2013.01); A61K 33/32 (2013.01); A61P 15/00 (2017.12); G16H 10/40 (2017.12); G16H 20/13 (2017.12); G16H 40/63 (2017.12); G16H 40/67 (2017.12); G16H 50/20 (2017.12); G16H 50/30 (2017.12); Y02A 90/10 (2017.12)

Citation (search report)

  • [XP] WO 2020123559 A1 20200618 - GLYCIOME LLC [US]
  • [Y] WO 2018013583 A2 20180118 - BRIGHAM & WOMENS HOSPITAL INC [US]
  • [Y] ROUSSEAU V ET AL: "Prebiotic effects of oligosaccharides on selected vaginal lactobacilli and pathogenic microorganisms", ANAEROBE, ELSEVIER, AMSTERDAM, NL, vol. 11, no. 3, 1 June 2005 (2005-06-01), pages 145 - 153, XP004807462, ISSN: 1075-9964, DOI: 10.1016/J.ANAEROBE.2004.12.002
  • [YD] YANG LIN ET AL: "Bornyl acetate suppresses ox-LDL-induced attachment of THP-1 monocytes to endothelial cells", BIOMEDICINE & PHARMACOTHERAPY, vol. 103, 1 July 2018 (2018-07-01), FR, pages 234 - 239, XP093106343, ISSN: 0753-3322, DOI: 10.1016/j.biopha.2018.03.152
  • [Y] IMBERT MARLÈNE ET AL: "On the Iron Requirement of Lactobacilli Grown in Chemically Defined Medium", CURRENT MICROBIOLOGY, vol. 37, no. 1, 1 July 1998 (1998-07-01), New York, pages 64 - 66, XP093106353, ISSN: 0343-8651, DOI: 10.1007/s002849900339
  • See references of WO 2021133697A1

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DOCDB simple family (publication)

WO 2021133697 A1 20210701; AU 2020415366 A1 20220714; EP 4081664 A1 20221102; EP 4081664 A4 20240110

DOCDB simple family (application)

US 2020066269 W 20201219; AU 2020415366 A 20201219; EP 20905639 A 20201219